Retrospective Follow-up of BIOLUX P-I/-II

The aim is to collect long-term clinical data from 132 patients from Belgium, Germany and Austria who had previously participated in either of the BIOLUX P-I or P-II studies. Patients in these studies...

Lead sponsor: Biotronik AG•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

UNKNOWN

Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chinese Population

NCT03154203 · Blood Pressure, Cardiovascular Risk Factor, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 5, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment132

Start dateFeb 2020

Last updatedAug 5, 2021

Condition

Overall Mortality

Locations shown

LKH Univ.-Klinikum Graz, Ambulanz für Angiologie

Graz

Allgemeines Krankenhaus - Universitätsklinik für Radiodiagnostik, Klinische Abteilung für Kardiovaskuläre und Interventionelle Radiologie

Vienna

Vascular Research Center Bornheiden, Imelda Hospital

Bonheiden

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 5, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions